TCRX logo

TScan Therapeutics (TCRX) EBIT

Annual EBIT

-$123.85 M
-$38.39 M-44.92%

December 31, 2024


Summary


Performance

TCRX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTCRXprofitabilitymetrics:

Quarterly EBIT

-$35.02 M
-$6.10 M-21.07%

December 31, 2024


Summary


Performance

TCRX Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTCRXprofitabilitymetrics:

TTM EBIT

-$123.85 M
-$16.26 M-15.12%

December 31, 2024


Summary


Performance

TCRX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTCRXprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

TCRX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-44.9%0.0%0.0%
3 y3 years-154.7%-59.1%-46.7%
5 y5 years-771.5%-59.1%-46.7%

TCRX EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-154.7%at low-146.7%at low-154.6%at low
5 y5-year-771.5%at low-523.7%at low-2097.4%at low
alltimeall time-771.5%at low-523.7%at low-2097.4%at low

TScan Therapeutics EBIT History

DateAnnualQuarterlyTTM
Dec 2024
-$123.85 M(+44.9%)
-$35.02 M(+21.1%)
-$123.85 M(+15.1%)
Sep 2024
-
-$28.93 M(-5.8%)
-$107.58 M(+6.9%)
Jun 2024
-
-$30.71 M(+5.2%)
-$100.67 M(+8.2%)
Mar 2024
-
-$29.18 M(+55.6%)
-$93.03 M(+8.9%)
Dec 2023
-$85.46 M(+31.4%)
-$18.76 M(-14.8%)
-$85.46 M(+1.2%)
Sep 2023
-
-$22.02 M(-4.6%)
-$84.45 M(+7.6%)
Jun 2023
-
-$23.08 M(+6.8%)
-$78.47 M(+11.3%)
Mar 2023
-
-$21.61 M(+21.7%)
-$70.50 M(+8.4%)
Dec 2022
-$65.05 M
-$17.75 M(+10.6%)
-$65.05 M(+5.8%)
Sep 2022
-
-$16.04 M(+6.3%)
-$61.50 M(+0.3%)
Jun 2022
-
-$15.10 M(-6.6%)
-$61.29 M(+7.8%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$16.16 M(+13.8%)
-$56.87 M(+16.9%)
Dec 2021
-$48.63 M(+85.4%)
-$14.20 M(-10.3%)
-$48.64 M(+15.1%)
Sep 2021
-
-$15.84 M(+48.3%)
-$42.25 M(+25.8%)
Jun 2021
-
-$10.68 M(+34.9%)
-$33.58 M(+17.8%)
Mar 2021
-
-$7.92 M(+1.4%)
-$28.52 M(+8.7%)
Dec 2020
-$26.23 M(+84.6%)
-
-
Dec 2020
-
-$7.81 M(+8.9%)
-$26.23 M(+42.4%)
Sep 2020
-
-$7.17 M(+27.7%)
-$18.42 M(+63.7%)
Jun 2020
-
-$5.62 M(-0.4%)
-$11.25 M(+99.6%)
Mar 2020
-
-$5.64 M
-$5.64 M
Dec 2019
-$14.21 M
-
-

FAQ

  • What is TScan Therapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for TScan Therapeutics?
  • What is TScan Therapeutics annual EBIT year-on-year change?
  • What is TScan Therapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for TScan Therapeutics?
  • What is TScan Therapeutics quarterly EBIT year-on-year change?
  • What is TScan Therapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for TScan Therapeutics?
  • What is TScan Therapeutics TTM EBIT year-on-year change?

What is TScan Therapeutics annual earnings before interest & taxes?

The current annual EBIT of TCRX is -$123.85 M

What is the all time high annual EBIT for TScan Therapeutics?

TScan Therapeutics all-time high annual earnings before interest & taxes is -$14.21 M

What is TScan Therapeutics annual EBIT year-on-year change?

Over the past year, TCRX annual earnings before interest & taxes has changed by -$38.39 M (-44.92%)

What is TScan Therapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of TCRX is -$35.02 M

What is the all time high quarterly EBIT for TScan Therapeutics?

TScan Therapeutics all-time high quarterly earnings before interest & taxes is -$5.62 M

What is TScan Therapeutics quarterly EBIT year-on-year change?

Over the past year, TCRX quarterly earnings before interest & taxes has changed by $0.00 (0.00%)

What is TScan Therapeutics TTM earnings before interest & taxes?

The current TTM EBIT of TCRX is -$123.85 M

What is the all time high TTM EBIT for TScan Therapeutics?

TScan Therapeutics all-time high TTM earnings before interest & taxes is -$5.64 M

What is TScan Therapeutics TTM EBIT year-on-year change?

Over the past year, TCRX TTM earnings before interest & taxes has changed by $0.00 (0.00%)